COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02992964
Recruitment Status : Recruiting
First Posted : December 14, 2016
Last Update Posted : February 5, 2020
Bristol-Myers Squibb
Information provided by (Responsible Party):
Daniel Morgenstern, The Hospital for Sick Children

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021